Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Beldi-Ferchiou A, Jais JP, Ghesquieres H, Casasnovas RO, Tilly H, Fruchart C, Morschhauser F, Haioun C, Lazarovici J, Perrot A, Nicolas-Virelizier E, Salles G, Godard N, Zamali I, De Colella JS, Claudel A, Corront B, Oberic L, Briere J, Gaulard P, Thieblemont C, Delfau-Larue MH. Beldi-Ferchiou A, et al. Br J Haematol. 2023 Apr;201(2):256-266. doi: 10.1111/bjh.18642. Epub 2023 Feb 6. Br J Haematol. 2023. PMID: 36740991 Clinical Trial.
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.
Abroud H, Beldi-Ferchiou A, Audard V, Lemonnier F, Le Bras F, Belhadj K, Moktefi A, Poullot E, El Karoui K, Dupuis J, Maarek A, Roulin L, Delfau-Larue MH, Oghina S, Kharoubi M, Bézard M, Zaroui A, Damy T, Molinier-Frenkel V. Abroud H, et al. Among authors: beldi ferchiou a. EJHaem. 2022 Jun 24;3(3):828-837. doi: 10.1002/jha2.516. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051065 Free PMC article.
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.
Moatti A, Debesset A, Pilon C, Beldi-Ferchiou A, Leclerc M, Redjoul R, Charlotte F, To NH, Bak A, Belkacemi Y, Salomon BL, Issa F, Michonneau D, Maury S, Cohen JL, Thiolat A. Moatti A, et al. Among authors: beldi ferchiou a. J Immunother Cancer. 2022 Apr;10(4):e003508. doi: 10.1136/jitc-2021-003508. J Immunother Cancer. 2022. PMID: 35387779 Free PMC article.
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F. Pasquer H, et al. Among authors: beldi ferchiou a. Br J Haematol. 2021 May;193(3):674-677. doi: 10.1111/bjh.17380. Epub 2021 Mar 13. Br J Haematol. 2021. PMID: 33713427 No abstract available.
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
Sokal A, Chappert P, Barba-Spaeth G, Roeser A, Fourati S, Azzaoui I, Vandenberghe A, Fernandez I, Meola A, Bouvier-Alias M, Crickx E, Beldi-Ferchiou A, Hue S, Languille L, Michel M, Baloul S, Noizat-Pirenne F, Luka M, Mégret J, Ménager M, Pawlotsky JM, Fillatreau S, Rey FA, Weill JC, Reynaud CA, Mahévas M. Sokal A, et al. Among authors: beldi ferchiou a. Cell. 2021 Mar 4;184(5):1201-1213.e14. doi: 10.1016/j.cell.2021.01.050. Epub 2021 Feb 2. Cell. 2021. PMID: 33571429 Free PMC article.
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
Lemonnier F, Safar V, Beldi-Ferchiou A, Cottereau AS, Bachy E, Cartron G, Fataccioli V, Pelletier L, Robe C, Letourneau A, Missiaglia E, Fourati S, Moles-Moreau MP, Delmer A, Bouabdallah R, Voillat L, Becker S, Bossard C, Parrens M, Casasnovas O, Cacheux V, Régny C, Camus V, Delfau-Larue MH, Meignan M, de Leval L, Gaulard P, Haioun C. Lemonnier F, et al. Among authors: beldi ferchiou a. Blood Adv. 2021 Jan 26;5(2):539-548. doi: 10.1182/bloodadvances.2020003081. Blood Adv. 2021. PMID: 33496747 Free PMC article. Clinical Trial.
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Gounot R, et al. Among authors: beldi ferchiou a. Leuk Lymphoma. 2021 Apr;62(4):979-983. doi: 10.1080/10428194.2020.1850717. Epub 2020 Nov 29. Leuk Lymphoma. 2021. PMID: 33251891 No abstract available.
26 results